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We analyze 25 previously identified transcription factor binding sites that carry DNA sequence changes 
that are present in all or nearly all present-day humans, yet occur in the ancestral state in Neandertals 
and Denisovans, the closest evolutionary relatives of humans. When the ancestral and derived forms 
of the transcription factor binding sites are tested using reporter constructs in three neuronal cell 
lines, the activity of 12 of the derived versions of transcription factor binding sites differ from the 
respective ancestral variants. This suggests that the majority of this class of evolutionary differences 





The closest evolutionary relatives of present-day humans are the Neandertals and Denisovans, two 
extinct hominins that lived in western Eurasia and Asia, respectively, and shared a common ancestral 
population with modern humans about 550,000 to 765,000 years ago (Prüfer et al. 2014). An 
interesting question is the extent to which these extinct hominins differed in their biology and 
cognition from modern humans, and if such differences may underlie the dramatic cultural, 
technological and demographic development that has characterized the evolution of modern humans 
(Paabo 2014).  
Recently, the genome of a Neandertal individual has been sequenced to high quality (Prüfer 
et al. 2014). This genome sequence, as well as a genome sequence previously generated from a 
Denisovan individual (Meyer et al. 2012), cover the approximately two thirds of the genome to which 
short DNA sequences can be mapped on average 42-fold and 30-fold, respectively. Together they 
make it possible to identify positions in the genome where the majority of present-day humans carry 
derived alleles, i.e. alleles that differ from the apes, and which are not seen in the Neandertal and 
Denisovan genomes. Since the two archaic genomes derive from populations that separated from 
each other some 381,000 to 473,000 years ago (although limited gene flow subsequently occurred 
between them) (Prüfer et al. 2014), such derived alleles are unlikely to have been prevalent in the two 
archaic groups. Instead, most of them result from new mutations or alleles that were present at low-
frequency in the ancestral population of the two archaic groups and modern humans and have since 
risen to high frequency or fixation among modern humans. These alleles are potentially interesting 
because some of them may influence biological traits unique to modern humans relative to other, 
 at M












extinct hominin groups. However, it is possible that the majority of these alleles have no biological 
effects, or effects that are too small to be of biological relevance. A crucial question is therefore if 
biological effects can be detected in this class of alleles, i.e. if some derived alleles that occur at high 
frequency in present-day humans have effects that differ from the ancestral alleles seen in the 
Neandertal and Denisovan genomes. 
Here we analyze 50 ancestral and derived allelic variants of 25 transcription factor binding 
sites with respect to their ability to drive transcription from a reporter construct in three neuronal cell 




A total of 145,159 single nucleotide changes and small insertions or deletions where the Neandertal 
and Denisovan genomes both carry only ancestral alleles, i.e. alleles inferred to have occurred in the 
common ancestor shared with chimpanzees, but where 90% or more of present-day humans carry 
derived variants have been previously identified (Prüfer et al. 2014). Among these variants, which have 
thus risen to high frequency or fixation in modern humans since their separation from archaic 
hominins, Prüfer et al. (2014) identified 14,497 that potentially affect “regulatory features” as defined 
by the Variant Effect Predictor (McLaren et al. 2010) in Ensemble based on features such as 
transcription factor binding, histone modifications and chromatin accessibility (Flicek et al. 2014). They 
noted that 139 of these affect transcription factor binding sites (TFBSs) as defined by the JASPAR data 
base (Mathelier et al. 2014), and that 25 of them affect positions in the TFBSs that may be important 
for their ability to bind transcriptional regulators (score > 1.5 according to Stormo (2000), see 
Supplementary Tables S18.1 and 18.3 in Prüfer et al. 2014). At 6 of these sites, all present-day humans 
investigated to date carry the derived variant, while at the remaining 19 sites the ancestral variant is 
present in less than 10% of present-day humans (Supplementary Table S1). For 20 of the sites there is 
direct evidence that they bind transcription factors in neurons or neuronal stem cells (Supplementary 
Table S2). 
To investigate if these 25 TFBS alleles differ in their ability to drive transcription in neuronal 
cells we cloned each TFBS variant as well as 25 nucleotides of flanking DNA on each side of the TFBSs 
upstream of a minimal promoter into reporter constructs (Figure 1) (Patwardhan et al. 2012). The 
promoter drives transcription from a reporter gene that carries 20-nt-long tags unique to each 
construct. As a positive control we prepared a similar reporter construct carrying a cytomegalovirus 
(CMV) enhancer and, as a negative control, a construct without any sequence inserted. 
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We pooled bacterial cultures carrying the 50 reporter plasmids as well as the positive and 
negative control plasmids and prepared DNA from the pools. These pools were transfected into two 
neuroblastoma cell lines (SH-SY5Y and IMR-32) and one neural progenitor cell line (Millipore 
ReNcell CX). Ten replicates of each transfection were performed and 24 hours after transfection RNA 
and DNA were isolated from the cells. From the RNA, transcripts from the reporter constructs were 
amplified after reverse transcription. From the DNA, the plasmids were amplified and sequenced in 
order to quantitate the molar ratios of the DNA pool in the cells. As a control for DNA carry-over into 
the RNA preparation, amplification from the RNA was performed without prior reverse transcription, 
and for each allelic form of the TFBSs the numbers of transcript observed when no reverse 
transcriptase had been added were subtracted from the numbers seen when cDNA had been 
synthesized. We then calculated the ratios of the transcripts observed for the derived TFBS variant 
over transcripts observed for the ancestral variant, and corrected for the ratios of the two 
corresponding DNA constructs extracted from the cells. Similarly, we calculated the ratios of 
transcripts observed for ancestral as well as derived TFBS variant over transcripts observed for the 
negative control and corrected for the ratios of the corresponding DNA constructs extracted from the 
cells (Supplementary Table S1). Differences were corrected for multiple tests within the three cell lines 
and p-values below 0.05 regarded as significant. 
When we calculate the ratios of the transcripts produced from the ancestral and derived 
versions of the TFBSs relative the negative control plasmid that lacks an inserted TFBS, we find that 
one of the TFBSs (chr2:9983591AGA) results in significantly more transcripts in all three cell lines, 
three do so in two cell lines and eight do so in one of the cell lines tested for at least one of the two 
variants (ancestral or derived). Thus, twelve of the TFBSs enhance transcription in the cell lines tested 
in their ancestral and/or derived variant. In contrast, only one of the TFBSs results in a significant 
reduction in numbers of transcripts (chr6:20212662T in SH-SY5Y cells) and thus may act as a repressor 
(Supplementary Table S1). 
Six derived TFBS alleles show significant increases and three show significant decreases in 
transcriptional activity relative to their ancestral alleles in SH-SY5Y cells while three derived TFBS 
alleles show significant increases in IMR-32 cells and one derived allele shows an increase in the 
neuronal progenitor cells (Figure 2, upper panel). Across all TFBSs, the ratios of the transcripts 
produced by the ancestral and derived variants are weakly but significantly correlated in the three cell 
lines (R(NPC and IMR-32) = 0.26; R(NPC and SH-SY5Y) = 0.30; R(IMR-32 and SH-SY5Y) = 0.41) and slightly more so in the two 
neuroblastoma lines (R=0.41). The average effect size of the differences between ancestral and 
derived variants is 1.8-fold. For seven of the TFBSs that show significant changes in transcript amounts 
between derived and ancestral variant, at least one variant produces significantly more or fewer 
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transcripts than the negative control (Figure 2, lower panel). For the remaining five TFBSs, the 
numbers of transcripts produced by one variant is always higher and the other lower than the negative 
control, albeit not significantly so (Figure 2, lower panel). Some of these variants may lack activity in 
one form tested, or might exert larger effects if present together with cofactors. 
In SH-SY5Y cells the largest significant change in relative transcriptional activity is caused by 
the chr10:118707481GC substitution, which reduces the expression of the derived allele to 38 % of 
that of the ancestral allele (p=0.01) and below the levels of the negative control (p=0.06). This TFBS is 
expected to be bound by the transcription factor AP-1 and according to the Transcribed Enhancer Atlas 
(Andersson et al. 2014; Forrest et al. 2014) it may affect six genes (Supplementary Table S2). Two of 
these, HSPA12A and KIAA1598, are highly expressed in the brain and encode a heat-shock protein and 
a protein involved in axonal induction, respectively. Transcripts from these two genes are less 
abundant in the frontal cortex of humans than of chimpanzees (Babbitt et al. 2010), as expected if the 
chr10:118707481GC substitution is responsible for this expression difference. Other potential 
target genes are PNLIP, which encodes a pancreatic lipase that is essential for the efficient digestion 
of dietary fats (van Bennekum et al. 2000), and PNLIPRP1 and 2, which encode pancreatic lipase-
related proteins. Interestingly, the PNLIP protein is one of only 87 proteins that carry a fixed amino 
acid change in modern humans relative to the Neandertal and Denisovan genomes (Prüfer et al. 2014). 
It is thus possible that both the regulation and activity of the pancreatic lipase have changed in modern 
humans.  
Interestingly, another AP-1 binding site experienced a CG substitution at position 
chr8:53608138. This substitution affects the same position in the TFBS but in the reciprocal direction 
to the chr10:118707481GC substitution. In the SH-SY5Y cells, the chr8:53608138CG substitution 
increases the transcriptional activity albeit not significantly (p=0.09), i.e. the effect is in the opposite 
direction to the reciprocal chr10:118707481GC substitution (Supplementary Table S1). The 
chr8:53608138CG substitution is located in the first intron of RB1CC1 and an enhancer transcript 
covering this site is correlated with the RNA transcript of RB1CC1 across a variety of tissues and 
primary cells (Andersson et al. 2014; Forrest et al. 2014). RB1CC1 encodes a transcription factor which 
is essential for maintaining adult neuronal stem cells in the subventricular zone of the cerebral cortex 
(Wang et al. 2013) and, like the PNLIP protein, the RB1CC1 protein is one of the 87 proteins that carry 
amino acid substitutions that are fixed in present-day humans but occur in the ancestral state in the 
Neandertal and Denisovan genomes. This change is located in one of 63 genomic regions for which 
there is evidence that they have been subject to positive selection in modern humans after their 
separation from archaic humans (Prüfer et al. 2014). It is thus tempting to speculate that the 
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regulation of the RB1CC1 gene and perhaps also the function of the encoded protein have changed 
and have been positively selected in modern humans. 
At least two other TFBSs may affect the expression of transcription factors and can thus have 
multiple downstream effects: chr2:9983591GA and chr10:124638514AG. The derived version of 
the substitution chr2:9983591GA is more active than the ancestral version in SH-SY5Y and IMR-32 
cells. It may influence four genes: KLF11, GRHL1, and TAF1B, which are transcription factors and 
ADAM17, which encodes a protease that modifies a number of transcription factors and receptors 
(Asano et al. 1999; Beckmann et al. 1995; Magrane and Consortium 2011; Wilanowski et al. 2002). The 
genes GRHL1, TAF1B, and ADAM17 all have higher transcript levels in frontal cortex of humans than 
of chimpanzees, whereas the expression of KLF11 does not differ between the two species (Babbitt et 
al. 2010). It is thus tempting to speculate that this change may increase the expression of GRHL1, 
TAF1B, and ADAM17 in humans which in turn may have numerous downstream effects. The 
substitution chr10:124638514AG may affect the transcription of the gene IKZF2, which encodes a 
transcription factor involved in hematopoietic development (Hahm et al. 1998). 
Several of the other changes that cause significant differences between the ancestral and 
derived alleles may warrant further analyses. For example, the TFBS affected by the substitution 
chr6:20212662GT seems to actively repress transcription in SH-SY5Y cells since its derived variant 
causes the expression to be significantly lower than in the negative control lacking a TFBS (p=0.03) 
(Supplementary Table S1). It may regulate the gene MBOAT1 which is involved in the development of 
the hand and foot (Dauwerse et al. 2007). The substitution chr6:4803919GA may abrogate the 
expression of the gene PPP1P3G which is involved in glycogenesis (Zhang et al. 2014), and 
chr2:216545780TC may increase the expression of the gene FN1 which encodes fibronectin, a 




Until about 30,000 or 40,000 years ago, several hominin forms existed besides modern humans, the 
direct ancestors of present-day humans. All these hominins were similar in that they controlled fire, 
produced stone tools, and lived in social groups. However, from about 60,000 or 70,000 years ago, 
one of these hominin groups, “modern humans”, started to spread out of Africa and the Middle East 
and replaced other hominins. They eventually developed technology that changed rapidly and became 
progressively more complex. Modern humans also started producing figurative art and spread across 
vast expanses of water, with time colonizing essentially all habitable parts of the globe and becoming 
several orders of magnitudes more numerous than what other hominins had ever been. Neandertals 
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and Denisovans never did these things although they existed for a longer time than modern humans 
have hitherto existed. It is tempting to speculate that this difference between modern and archaic 
humans had to do with cognitive differences between modern humans and other hominins (Klein 
1999; Mellars 2006; Paabo 2014). However, it is still debated if these dramatic cultural and historical 
developments reflect any biological differences between modern and archaic humans or if they 
represent contingent cultural innovations unique to modern humans. It is thus a relevant question if 
genetic differences between present-day humans and Neandertals and Denisovans have 
consequences for the phenotype or not, particularly in the brain. Of special interest are differences 
that may influence gene expression as they may be particularly likely to affect phenotypic traits that 
differ between closely related populations and species (Wray et al. 2003).  
To begin to address the question if DNA sequences that influence gene expression in neuronal 
tissues may differ between modern humans and Neandertals and Denisovans we analyzed 25 TFBSs 
which carry derived variants at high frequency among present-day humans that do not occur in the 
Neandertal and Denisovan genomes and for which there are indications that they could be of 
functional significance. In 12 cases we find that the derived and ancestral alleles differ significantly in 
their ability to drive transcription in at least one of three cell lines. Given that we tested only three cell 
lines and used a single reporter construct which may not allow each TFBS to exert its effects, the fact 
that we find differences between the two alleles for almost half of the TFBSs tested strongly suggests 
that a large fraction if not all of them affect the expression of target genes.  
Although a difference in mRNA expression does not necessarily influence any biologically 
relevant phenotype (Khaitovich et al. 2005; Khaitovich et al. 2004) there is some evidence that at least 
some of the changes analyzed here may have been positively selected. For example, the 
chr10:118707481GC substitution which may regulate the gene RB1CC1 is located in a region that 
has previously been suggested to be positively selected in modern humans after their separation from 
Neandertals and Denisovans (Prüfer et al. 2014). We thus suggest that the regulatory changes tested 
here as well as others that have recently risen to high frequency in humans are likely to have effects 
that have been of relevance for the evolution of the phenotypes that set modern humans apart from 

















Cloning of TFBSs into pGL4.23 plasmid. 
The 50 TFBSs were from GeneArt Gene Synthesis. In each case, we centered the synthesized fragments 
on variable nucleotides and included 25 base pairs in each direction as well as Kpn I and Nhe I 
restriction sites. The TFBSs as well as a CMV enhancer (GenBank: U02451.1; nucleotides 18-431) were 
cloned into the pGL4.23 plasmid (Promega) and grown in E. coli DH5alpha (New England Biolabs) and 
clones from each transformation were pooled and DNA extracted using the Qiaprep Spin Miniprep Kit. 
We synthesized a single-stranded oligonucleotide of 20 random bases (AAC CAT AGG ATT CGC GTC 
AGT CTA GAT AGN NNN NNN NNN NNN NNN NNN NGG CCG GCC GTC TGG CGT CTT GGC TAA TC) 
flanked on the 5’-end by an Xba I site and the sequence “TAG” and an Fse I site on the 3’-end 
(Invitrogen) as well as primer sites used to make the oligo double stranded by two cycles of PCR 
(Thermo Scientific Phusion polymerase, annealing temperature 60 °C, Primers AAC CAT AGG ATT CGC 
GTC AG and GAT TAG CCA AGA CGC CAG AC). The tags were cloned into the pGL4.23 plasmids carrying 
the TFBSs between the Kpn I and Nhe I sites, the CMV promoter, or no insert. DNA was extracted from 
individual clones using the Qiaprep Spin Miniprep Kit and colony PCR was performed (Thermo 
Scientific Phusion polymerase, annealing temperature 60 °C, primers TTT TTG TGT GAA TCG ATA GTA 
CTA ACA TAC GCT and GAG CTT CCA TTA TAT ACC CTC TAG TGT CTA AGC for regulatory regions, primers 
AGA TTC TCA TTA AGG CCA AGA AGG G and TCA CTG CAT TCT AGT TGT GGT TTG TCC for tag region). 
Plasmids that matched expected insert sizes for both amplifications were used to construct Illumina 
sequencing libraries (Meyer and Kircher 2010) and fully sequenced on an Illumina MiSeq (paired end 
2x (150bp + 7bp)) for sequence-verification and association of the tags with TFBSs. 
 
Transfection of cell lines. 
Overnight cultures of clones with sequence-verified plasmids were set up (one per TFBS variant, three 
for chr1:26376528C, two for chr1:26376528T, a CMV positive control, a negative control plasmid). The 
next day, 5 ml of each (10 µl of CMV plasmid) were pooled and plasmids prepared (Invitrogen HiPure 
Plasmid Filter Midiprep). Neuronal cell lines (SH-SY5Y - ATCC; IMR-32 - ATCC; NPC - Millipore) were 
cultured according to the protocols provided by the vendors and transfected with 2 µg of the plasmid 
pool, using a Lonza Nucleofector 2b device and the Lonza Amaxa Nucleofector kits (V, L, and Mouse 
NSC, respectively) and recommended nucleofection programs (A-030, C-005, and A-033, respectively). 
Twenty four hours after transection, cells were harvested, pellets were flash-frozen in liquid nitrogen 
and stored at -80 °C. 
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Nucleic acid isolation and sequencing. 
Cell pellets were resuspended in 350 µl Qiagen RLT buffer and homogenized using QiaShredder 
columns. Seventy microliter were used for plasmid purification (Qiaquick PCR Purification Kit) and the 
remaining 270 microliter for RNA purification (Qiagen RNeasy Mini Kit). After incubation with 
20 microliter of DNase I solution (Qiagen RNase free DNase Kit) for 60 minutes at RT, mRNA was 
isolated (Thermo Scientific MagJET mRNA Enrichment Kit) and split into an RTminus aliquot and an 
aliquot that was reverse transcribed (Thermo Scientific DyNAmo cDNA Synthesis Kit). 
Both RNA samples and the plasmid samples were subjected to qPCR (New England Biolabs 
DyNAmo Flash SYBR Green qPCR Kit) using primers amplifying the tag region as described (Meyer and 
Kircher 2010). Reactions were stopped one cycle after the steepest increase of the qPCR curve of the 
RTplus reaction and indexing PCR for sequencing was done as described (Meyer and Kircher 2010), 
while taking care to stop also the indexing reactions when the RTplus curve passed the inflection point 
in order to not saturate the PCRs of RTplus samples. 
After sequencing (Illumina MiSeq, paired end 2x (150bp + 7bp)) and base-calling (Bustard, 
Illumina), overlapping paired-end reads were merged using leeHom (Renaud et al. 2014a), tags 
associated with TFBS alleles using deML (Renaud et al. 2014b), and the number of occurrences of each 
tag counted (Supplementary Table S3).  
 
Analyses of transcript numbers. 
All analyses were implemented in R (version 3.0.3) (R Core Team 2014) using Tinn-R (FARIA 2013). 
Replicates were excluded from the analysis when count numbers for a variant were unusually high in 
the RTminus sample or unusually low in the RTplus sample compared to all other replicates (as 
indicated in Supplementary Table S3 and Supplementary Figure S1). For any given replicate of a TFBS, 





𝐝 𝐑𝐓𝐩𝐥𝐮𝐬 − 𝐝 𝐑𝐓𝐦𝐢𝐧𝐮𝐬





Ratios of tags expressed from TFBSs over the negative control were similarly calculated 
(Supplementary Table S1). One sample T-tests (R: t.test(x)) were used to assess whether the 
normalized ratios of tag counts differ from 0 (i.e. no difference in transcript numbers). Similarly, T-tests 
were used to assess whether the transcript numbers of a given TFBS variant differ from that of the 
negative control. P-values were corrected for multiple testing within each cell line (Benjamini and 
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Hochberg 1995) (R: p.adjust(method=”BH”)) and p-values smaller than 0.05 were regarded 




Transcription start sites were defined according to RefSeq release 63 (Pruitt et al. 2009) using the 
function findClosestGene in the R package ACME (Scacheri et al. 2006) and enhancer-transcription 
start site associations were from the Transcribed Enhancer Atlas database (Andersson et al. 2014; 
Forrest et al. 2014). All transcription factors that bind to the TFBSs according to JASPAR 
(Supplementary Table S2) are expressed in the human brain according to Human Body Map 2.0 dataset 
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Supplementary Figure S1: Excluded replicates. A: Excluded replicates of RTminus samples. Samples 
that were not reverse transcribed were used to estimate the background. In 30 out of 1,650 replicates 
transcript counts were >200 (red) and these were excluded from the analyses (see Supplementary 
Table S3). B: Excluded replicates of RTplus samples. Similarly, reverse transcribed samples with fewer 
than 200 transcripts were excluded from the analyses (Supplementary Table S3).  
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Supplementary Table S1: Transcriptional activity of TFBS variants over the negative control and 
transcriptional activity of derived TFBS variants over ancestral TFBS variants. 
 
Supplementary Table S2: Putative target genes and transcription factors binding the TFBSs analyzed. 
 
Supplementary Table S3: Transcript numbers of individual transcription factor binding site variants 














Derived and ancestral variants of transcription factor binding 
motifs with evolutionary changes towards present-day humans Degenerate 20 bp tags
Minimal promoter / luciferase polyA
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sequences and regulatory variants
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Figure 1: Overview of the RNA reporter assay. We synthesized 25 pairs of DNA sequences that carry 
ancestral (red) or derived (green) allelic variants of TFBSs and cloned them along with 20-nucleotide-
long tag sequences into a reporter vector (pGL4.23) containing a minimal promoter and the luciferase 
gene. The plasmids were sequenced to associate tags with TFBS variants, and plasmids prepared from 
mixed cultures of the 50 plasmids were transfected into SH-SY5Y cells, IMR-32 cells and neural 
progenitor cells. RNA and plasmids were isolated after 24h, and tag regions were amplified from the 
DNA and the reverse-transcribed RNA and sequenced. After correction for molar ratios of the plasmids 
in the cells, tag counts were compared for ancestral and derived versions of the TFBSs. Figure adopted 
from Patwardhan et al. (2012). 
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Figure 2: Transcription factor binding sites for which ancestral variants seen in Neandertals and 
Denisovans and derived variants seen in present-day humans differ in their ability to generate 
transcripts. TFBSs with significant differences between ancestral and derived variant are shown 
(upper panel) as well as the transcriptional activity of the ancestral and derived variants relative a 
negative control (lower panel). Note that the fold-change scale has no values between +1 and -1 and 
that +1.0 as well as -1.0 indicates no difference in transcriptional activity. NPC = neural progenitor 
cells. (*= p<0.05, **= p<0.01, ***= p<0.001). 
 at M
ax Planck Institut Fuer Evolutionaere A
nthropologie on N
ovem
ber 16, 2015
http://m
be.oxfordjournals.org/
D
ow
nloaded from
 
